{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:39:37Z","timestamp":1761129577301,"version":"3.37.3"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T00:00:00Z","timestamp":1536278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grant-in-Aid for Scientific Research, Japan Society for the Promotion of Science","award":["16K09155"],"award-info":[{"award-number":["16K09155"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0203815","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T17:53:02Z","timestamp":1536342782000},"page":"e0203815","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["A situational analysis of latent tuberculosis infection among incarcerated population in Japan"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2666-844X","authenticated-orcid":true,"given":"Lisa","family":"Kawatsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Uchimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4402-9855","authenticated-orcid":true,"given":"Akihiro","family":"Ohkado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,9,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.282.7.677","article-title":"Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country, WHO Global Surveillance and Monitoring Project","volume":"282","author":"C Dye","year":"1999","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a121593","article-title":"The prognosis of a positive tuberculin reaction in childhood and adolescence","volume":"99","author":"G Comstock","year":"1974","journal-title":"Am I Epidemiol"},{"key":"ref3","unstructured":"WHO. Implementing the end TB strategy: the essentials. 2015. WHO, Geneva. WHO\/HTM\/TB\/2015.31."},{"key":"ref4","unstructured":"WHO. Guidelines on the management of latent tuberculosis infection. 2015. WHO, Geneva. WHO\/HTM\/TB\/2015.01"},{"key":"ref5","unstructured":"The Ministry of Justice. Kyosei Tokei (Statistics of correctional facilities). <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.moj.go.jp\/housei\/toukei\/toukei_ichiran_kousei.html\" xlink:type=\"simple\">http:\/\/www.moj.go.jp\/housei\/toukei\/toukei_ichiran_kousei.html<\/ext-link>"},{"key":"ref6","unstructured":"Ishikawa N, Kawatsu L. Hokenjo ni muketa keiji shisetu ni okeru kekkaku taisakuno tebiki (\u201cGuideline for public health centers on coordinating with correctional facilities in controlling TB\u201d). 2014. The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Japan. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.jata.or.jp\/dl\/pdf\/data\/2014_a.pdf\" xlink:type=\"simple\">www.jata.or.jp\/dl\/pdf\/data\/2014_a.pdf<\/ext-link> (accessed 2018 April 12)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"921","DOI":"10.5588\/ijtld.14.0692","article-title":"Overview of the tuberculosis burden in prison institutions in Japan, 2000\u20132012","volume":"19","author":"L Kawatsu","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref8","first-page":"497","article-title":"Treatment Guideline on LTBI","volume":"88","year":"2013","journal-title":"Kekkaku"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"871","DOI":"10.5588\/ijtld.11.0447","article-title":"Isonizid preventive therapy in correctional facilities: a systematic review","volume":"16","author":"HAA Al-Darraji","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1164\/ajrccm\/140.5.1194","article-title":"Compliance with isoniazid prophylaxis in jail","volume":"140","author":"P Alcabes","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"ref11","first-page":"1248","article-title":"Contact screening and latent tuberculosis infection treatment in Singapore correctional facilities","volume":"9","author":"C Chee","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"e0186588","DOI":"10.1371\/journal.pone.0186588","article-title":"Trend and treatment status of latent tuberculosis infection patients in Japan\u2013analysis of Japan TB surveillance data","volume":"12","author":"L Kawatsu","year":"2017","journal-title":"PLOS ONE"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1164\/ajrccm.155.2.9032198","article-title":"Goldberg SV, Elarth AM. Directly observed isoniazid preventive therapy for released inmates","volume":"155","author":"C Nolan","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"ref14","first-page":"506","article-title":"A clinical trial of a financial incentive to go to the tuberculosis clinic for isoniazid after release from jail","volume":"2","author":"MC White","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.88.2.223","article-title":"Screening for tuberculosis in jail and clinic follow-up after release from jail","volume":"88","author":"JP Tulsky","year":"1998","journal-title":"Am J public Health"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/her\/cyg109","article-title":"Improving tuberculosis therapy completion after jail: translation of research to practice","volume":"20","author":"MC White","year":"2005","journal-title":"Health Edu Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archinte.162.9.1044","article-title":"Randomized controlled trial of interventions to improve follow-up for latent tuberculosis infection after release from jail","volume":"162","author":"MC White","year":"2002","journal-title":"Arch Intern Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s11524-010-9438-4","article-title":"Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment","volume":"87","author":"SA Springer","year":"2010","journal-title":"J Urban Health"},{"issue":"Suppl1","key":"ref19","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","article-title":"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care setting: results from a multisite study","volume":"56","author":"FL Altice","year":"2011","journal-title":"J Acquir Immunue Defic Syndr"},{"key":"ref20","article-title":"The profile of inmates with tuberculosis in Japan","author":"L Kawatsu","year":"2018","journal-title":"Int J of Prisoner Health"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1164\/ajrccm.161.supplement_3.ats600","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"161","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"ref22","first-page":"306","article-title":"Completing tuberculosis prophylaxis in jail: targeting treatment and comparison of rifampin\/pyrazinamide with isoniazid regimens","volume":"8","author":"T Lincoln","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1378\/chest.119.3.833","article-title":"Acceptability of short-course rifampin and pyrazinamide treatment for latent tuberculosis infection in jail inmates","volume":"119","author":"NN Bock","year":"2001","journal-title":"Chest"},{"key":"ref24","first-page":"1650","article-title":"Recommendations for use of an isoniazid-refapentine regimen with direct observation to treat latent <italic>Mycobacterium<\/italic> infection","volume":"60","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12879-017-2377-x","article-title":"Efficacy and completion rates of rifapentine and isoniazid (3HP) compared to other treatment regimens for latent tuberculosis infection: a systematic review with network meta-analyses","volume":"17","author":"C Pease","year":"2017","journal-title":"BMC Infectious Diseases"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0203815","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T21:00:54Z","timestamp":1588971654000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0203815"}},"subtitle":[],"editor":[{"given":"Pere-Joan","family":"Cardona","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,7]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0203815","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,9,7]]}}}